QUADRANT CAPITAL GROUP LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1650717
CINCINNATI, OH
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,301,486
-$539,511 QoQ
Shares Held
3,691
+0.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#500
of 1,328 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $22,827,015 across 21 Biotechnology names. REGN ranks #3 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,887 | $2,678,471 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,938 | $2,452,852 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
3,691 | $2,301,486 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
5,658 | $1,788,437 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
49,246 | $1,742,815 | |
| 6 | EXEL |
Exelixis, Inc.
|
30,229 | $1,644,759 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,605 | $1,398,754 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
4,647 | $1,324,255 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,301,486 | 3,691 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,840,997 | 3,677 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,791,853 | 3,617 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,006,179 | 3,568 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,052,100 | 2,004 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,707,347 | 2,692 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $605,480 | 850 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,069,111 | 1,017 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,069,948 | 1,018 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $930,727 | 967 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $842,280 | 959 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $748,070 | 909 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $654,589 | 911 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $785,516 | 956 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $601,001 | 833 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $540,074 | 784 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $375,367 | 635 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $398,099 | 570 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $340,389 | 539 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $309,246 | 511 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $255,811 | 458 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $205,342 | 434 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $156,527 | 324 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $173,531 | 310 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $179,611 | 288 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $339,343 | 695 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||